Close Menu

NEW YORK (GenomeWeb) – Guardant Health said today that it has priced its previously announced underwritten public offering of 4.5 million shares of common stock at $71.00 per share.

The company has also granted underwriters a 30-day option to purchase up to an additional 675,000 shares of its common stock at the public offering price. Guardant expects resulting gross proceeds of $319.5 million, excluding any exercise of the underwriters' additional share purchase option.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.